DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 30 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $30,000 | – | 14,691 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Manatuck Hill Partners, LLC | 272,400 | $564,000 | 0.31% |
| Worth Venture Partners, LLC | 141,801 | $294,000 | 0.17% |
| Granite Point Capital Management, L.P. | 227,230 | $470,000 | 0.07% |
| Stonepine Capital Management, LLC | 13,705 | $28,000 | 0.03% |
| WEXFORD CAPITAL LP | 88,860 | $184,000 | 0.03% |
| Patriot Financial Group Insurance Agency, LLC | 2,000 | $4,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 15,399 | $31,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 70,919 | $145,000 | 0.00% |
| TORONTO DOMINION BANK | 24 | $0 | 0.00% |
| BANK OF MONTREAL /CAN/ | 310 | $1,000 | 0.00% |